中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 11
Nov.  2014

Experimental study on hepatocyte apoptosis induced by acute biliary tract infection

DOI: 10.3969/j.issn.1001-5256.2014.11.018
  • Received Date: 2014-05-21
  • Published Date: 2014-11-20
  • Objective To examine the occurrence and possible mechanism of hepatocyte apoptosis in acute biliary tract infection. Methods After adaptive feeding for seven days, 30 male rats were randomly divided into five groups (n = 6 each) , i. e., one control group injected with 0. 2 ml of saline through the common bile duct and four experimental groups injected with an equal volume of Escherichia coli cell suspension to build an acute biliary tract infection model. Animals of the control group were killed 6 h after injection of saline, and those of the four experimental groups were killed respectively at the time points of 6, 12, 24, and 48 h after injection of E. coli. Liver tissue specimens were taken from all the rats to prepare tissue sections. Pathological features were examined by hematoxylin- eosin staining and light microscopy. Hepatocyte apoptosis was examined by cell counting after TUNEL staining and calculation of the apoptotic index. The expression of apoptosis- related proteins (Bcl- 2 and Bax) was measured by immunohistochemistry. Data comparison between groups was performed by analysis of variance, and pairwise comparisons were further conducted using the LSD- t test and Dunnett's T3 test. Results Tissue specimens of the control groups had no significant pathological changes, while those of the experimental groups showed hepatocyte apoptosis.Compared with the control group, the four experimental groups had significantly greater values of apoptotic index (P < 0. 05) . Additionally, the values of apoptotic index in the 24 and 48 h experimental groups significantly increased over time compared with that of the 12 h experimental group (P < 0. 05) . Bax protein expression level significantly differed between the control group and the experimental groups ( P<0. showing="" a="" slight="" increasing="" trend="" over="" time="" in="" the="" latter="" four="" groups="" p="">0. 05) . Bcl- 2 protein expression level had no significant differences between the control group and the 6 or 12 h experimental groups (P > 0. 05) . Over time, however, significant differences were observed in Bcl- 2 expression level between the 12 h experimental group and the 24 or 48 h experimental group (P < 0. 05) . Conclusion Hepatocyte apoptosis occurs within a short time after acute biliary tract infection. It persists in the whole process of the infection, with increased expression of Bax (inducer of apoptosis) and decreased expression of Bcl- 2 (inhibitor of apoptosis) . The changes in the expression of apoptosis- related genes coincide with hepatocyte apoptosis, suggesting that hepatocyte apoptosis may be associated with Bax and Bcl-2 genes.

     

  • [1]KERR JFR, WYLLIE AH, CURRIE AR.Apoptosis:a basic biological phenomenon with wide ranging implications in tissue kinetics[J].Br J Cancer, 1972, 26 (4) :239-257.
    [2]LAHORTE CM, VANDERHEYDEN JL, STEINMETZ N, et al.Apoptosis-detecting radioligands:current state of the art and future perspectives[J].Eur J Nucl Med Mol Imaging, 2004, 31 (6) :887-919.
    [3]XIA XM, HE K, FENG CH, et al.Cholangitis and hepatocyte apoptosis and expression of apoptosis gene[J].China J Modern Med, 2006, 16 (2) :233-236, 240. (in Chinese) 夏先明, 贺凯, 冯春红, 等.胆道感染与肝细胞凋亡及凋亡相关基因的表达[J].中国现代医学杂志, 2006, 16 (2) :233-236, 240.
    [4]LALISANG TJ, SJAMSUHIDAJAT R, SIREGAR NC, et al.Profile of hepatocyte apoptosis and bile lakes before and after bile duct decompression in severe obstructive jaundice patients[J].Hepatobiliary Pancreat Dis Int, 2010, 9 (5) :520-523.
    [5]FICKERT P, TRAUNER M, FUCHSBICHLER A, et al.Oncosis represents the main type of cell death in mouse models of cholestasis[J].J Hepatol, 2005, 42 (3) :378-385.
    [6]MALHI H, GORES G J, LEMASTERS JJ.Apoptosis and necrosis in the liver:A tale of two deaths[J].Hepatology, 2006, 43 (2Suppl 1) :s31-s44.
    [7]LASTER SM, GOOD JG, GOODING LR, et al.Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis[J].J Immunol, 1988, 141 (8) :2629-2634.
    [8]WANG JX, WANG GJ, CAI X.The effects of oxymatrine on apoptosis induced by TNF-αin human liver cell line L02[J].J Clin Hepatol, 2011, 17 (4) :210-221. (in Chinese) 王俊学, 王国俊, 蔡雄.氧化苦参碱对肿瘤坏死因子诱导的人L02肝细胞凋亡的影响[J].临床肝胆病杂志, 2011, 17 (4) :210-221.
    [9]LEIST M, GANTER F, BOHLINGER I, et al.Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest[J].J Immunol, 1994, 153 (4) :1778-788.
    [10]YAO YZ, BAO ZJ.Diagnostic value of serum IL-6, IL-8 and TNF-αin monitoring inflammation after operation of biliary tract infection[J].J Med Res, 2012, 41 (4) :104-106. (in Chinese) 姚燕珍, 鲍舟君.血清IL-6、IL-8和TNF-α在胆道术后感染监测中的价值[J].医学研究杂志, 2012, 41 (4) :104-106.
    [11]LEON CG, TORY R, JIA J, et al.Discovery and development of tolllike receptor 4 (TLR4) antagonists:a new paradigm for treating sepsis and other diseases[J].Pharm Res, 2008, 25 (8) :1751-1761.
    [12]YI JM, GUAN YS.Process and mechanism of inflammatory response following biliary obstruction[J].Chin J Gen Surg, 2012, 21 (5) :607-610. (in Chinese) 易杰明, 关养时.胆道梗阻后炎症反应发生的过程及机制[J].中国普通外科杂志, 2012, 21 (5) :607-610.
    [13]CHEN G, ZHOU SQ.Difference in the expression of iNOS in hepatocytes of rat with biliary tract infection and with abdominal infection[J].Chin J Exp Surg, 2003, 20 (12) :1083-1084. (in Chinese) 陈刚, 邹声泉.胆道感染与腹腔感染大鼠肝细胞诱生型一氧化氮合酶表达差异的实验研究[J].中华实验外科杂志, 2003, 20 (12) :1083-1084.
    [14]ZHAO Y, LI L, YIN Q.Effects of iNOS-derived NO on Bcl-2and Bax protein expression following focal cerebral ischemia and reperfusion in rats[J].Chin J Neuroanatomy, 2005, 21 (5) :539-542. (in Chinese) 赵昱, 李莉, 尹青.大鼠局灶性脑缺血再灌注中iNOS源性NO对Bcl-2, Bax表达的影响[J].神经解剖学杂志, 2005, 21 (5) :539-542.
    [15]MATSUDA T, SAITO H, FUKATSU K, et al.Cytokine-modulated inhibition of neutrophil apoptosis at local site augments exudative neutrophil functions and reflects inflammatory response after surgery[J].Surgery, 2001, 129 (1) :76-85.
    [16] YOULE RJ, STRASSER A.The Bcl-2 protein family:opposing activities that mediate cell death[J].Nat Rev Mol Cell Biol, 2008, 9 (1) :47-59.
    [17]WANG JT, GONG SS.Effects of siRNA specific to the protein kinase CK2αon apoptosis of laryngeal carcinoma cells[J].Chin Med J (Engl) , 2012, 125 (9) :1581-1585.
    [18]KOBAYASHI T, SAWA H, MORIKAWA J, et al.Bax induction activates apoptotic cascade via mitochondrial cytochrome C release and bax overexpression enhances apoptosis induced by chemotherapeutic agents in dld-1 colon cancer cells[J].Jpn J Cancer Res, 2000, 91 (12) :1264-1268.
    [19]SPRICK MR, WALCZAK H.The interplay between the Bcl-2family and death receptor-mediated apoptosis[J].Biochim Biophys Acta, 2004, 1644 (2-3) :125-132.
  • Relative Articles

    [1]Huaqiang ZHANG, Lixin LIU, Xiaohong GUO. Association of nonalcoholic fatty liver disease with the risk of colorectal adenoma and colorectal cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(7): 1619-1625. doi: 10.3969/j.issn.1001-5256.2021.07.028
    [2]Qiaohong LIU, Yu ZHAO, Yiyang HU. Effect of diet on enterotype-related gut microbiota in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(4): 939-942. doi: 10.3969/j.issn.1001-5256.2021.04.046
    [3]Juan PENG, Liangping LI. Mechanism of action of estrogen and its receptor in the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(2): 467-470. doi: 10.3969/j.issn.1001-5256.2021.02.046
    [4]Jinhong TANG, Long WANG. Research advances in the association between nonalcoholic fatty liver disease and colorectal adenomatous polyps[J]. Journal of Clinical Hepatology, 2021, 37(11): 2672-2675. doi: 10.3969/j.issn.1001-5256.2021.11.040
    [5]Yalan LEI, Jian BI, Jingwei MAO. Impact of nonalcoholic fatty liver disease on intestinal immune cells[J]. Journal of Clinical Hepatology, 2021, 37(11): 2667-2671. doi: 10.3969/j.issn.1001-5256.2021.11.039
    [6]Shenglan ZENG, Rongzhen ZHANG, Na WANG, Tingshuai WANG, Liting TAN, Dewen MAO. Effect of diet-gut microbiota axis on nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(11): 2676-2679. doi: 10.3969/j.issn.1001-5256.2021.11.041
    [7]Chenlu ZHAO, Wenxia ZHAO. Influence of estrogen deficiency on metabolic associated fatty liver disease in postmenopausal women[J]. Journal of Clinical Hepatology, 2021, 37(7): 1708-1712. doi: 10.3969/j.issn.1001-5256.2021.07.049
    [8]Tian TIAN, Wenwei HU, Xue LI, Jie WU, Dan ZHANG, Changzheng LI. Association between thyroxine level and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2357-2363. doi: 10.3969/j.issn.1001-5256.2021.10.020
    [9]Xiangqian HUANG, Xiaomeng YAN, Mingda ZHANG, Jing WU, Jianhong CHEN. Association between nonalcoholic fatty liver disease and colorectal neoplasms[J]. Journal of Clinical Hepatology, 2021, 37(12): 2947-2950. doi: 10.3969/j.issn.1001-5256.2021.12.045
    [10]SUN MengYuan, XIANG XiaoXing. Role of gut microbiota and bile acid pathway in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(12): 2831-2834. doi: 10.3969/j.issn.1001-5256.2020.12.040
    [11]Li HongShan, Hu YiYang. Gut microecology: An important target of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(1): 14-18. doi: 10.3969/j.issn.1001-5256.2020.01.002
    [12]Hui DengCheng, Sun MingYu. Association between nonalcoholic fatty liver disease and gut microbiota based on the theory of gut-liver axis[J]. Journal of Clinical Hepatology, 2020, 36(7): 1627-1630. doi: 10.3969/j.issn.1001-5256.2020.07.039
    [13]Zhang Dan, Zhou Bo, Deng Yi, Wen Yu, Lu: JunYan, Wang JinXiang, Geng ZuoTao, Luo SuFeng, Ying YunYan, Wen DaiYan, Shi ChunJing, Pu GuangYu, Jiang Xin, Ma LanQing. Effect of fenofibrate on the diversity of intestinal flora in a mouse model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(4): 829-834. doi: 10.3969/j.issn.1001-5256.2020.04.024
    [14]Chuan LiXue, Chang Jiang, Zhao JinHan, Li LuoHua, Yang XuYao, Yu Di. Association between nonalcoholic fatty liver disease and colorectal adenomatous polyps[J]. Journal of Clinical Hepatology, 2020, 36(6): 1299-1303. doi: 10.3969/j.issn.1001-5256.2020.06.022
    [15]Feng Gong, He Na, Mi Man, Li XuePing, Liu ManLing, Fan LiPing, Niu ChunYan. Risk factors for the coexistence of inflammatory bowel disease and nonalcoholic fatty liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(4): 835-839. doi: 10.3969/j.issn.1001-5256.2019.04.025
    [16]Liu SiFu, Xie ZhengYuan. Association between nonalcoholic fatty liver disease and colorectal tumors[J]. Journal of Clinical Hepatology, 2019, 35(9): 2091-2094. doi: 10.3969/j.issn.1001-5256.2019.09.046
    [17]Zhang XiaXia, Xu HongTuan, Xu YouQing. The natural history and clinical features of nonalcoholic fatty liver disease-related cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(1): 24-26. doi: 10.3969/j.issn.1001-5256.2018.01.004
    [18]Liu JiaQi, Zhou ShaoMing. Research advances in intestinal flora in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2453-2456. doi: 10.3969/j.issn.1001-5256.2017.12.045
    [19]Lu Xu, Han Tao, Tian Yao, Lu BoWei, Zhang Qian. Research progress in roles of gut microbiota and bile acid metabolism in development and progression of NAFLD[J]. Journal of Clinical Hepatology, 2014, 30(11): 1225-1228. doi: 10.3969/j.issn.1001-5256.2014.11.034
    [20]Zhu Peng, Xu Zong, Wang YuMing. World Gastroenterology Organisation global guidelines:nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2014, 30(9): 842-845. doi: 10.3969/j.issn.1001-5256.2014.09.002
  • Cited by

    Periodical cited type(3)

    1. 黄嘉卿. NNN-链接护理模式对血小板减少症患者睡眠质量及自我感受影响研究. 世界睡眠医学杂志. 2024(02): 378-381 .
    2. 赵静雯,王溶,杨隽芃. 艾尔巴韦格拉瑞韦片治疗继发性丙型肝炎病毒感染的效果观察. 中国处方药. 2023(04): 97-99 .
    3. 戴兆东. 直接抗病毒药物对丙型肝炎肝硬化患者的临床疗效分析. 抗感染药学. 2023(12): 1308-1311 .

    Other cited types(0)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 3.1 %FULLTEXT: 3.1 %META: 91.5 %META: 91.5 %PDF: 5.4 %PDF: 5.4 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 6.0 %其他: 6.0 %其他: 2.0 %其他: 2.0 %Canada: 0.2 %Canada: 0.2 %Central District: 0.2 %Central District: 0.2 %India: 0.2 %India: 0.2 %Kao-sung: 0.2 %Kao-sung: 0.2 %Rochester: 0.2 %Rochester: 0.2 %Taoyuan District: 0.2 %Taoyuan District: 0.2 %[]: 0.2 %[]: 0.2 %上海: 3.5 %上海: 3.5 %东莞: 0.3 %东莞: 0.3 %乌鲁木齐: 0.3 %乌鲁木齐: 0.3 %北京: 8.2 %北京: 8.2 %匹兹堡: 0.2 %匹兹堡: 0.2 %南京: 0.2 %南京: 0.2 %南宁: 0.6 %南宁: 0.6 %厦门: 0.8 %厦门: 0.8 %台州: 0.3 %台州: 0.3 %合肥: 0.3 %合肥: 0.3 %吉林: 0.6 %吉林: 0.6 %商洛: 0.3 %商洛: 0.3 %嘉兴: 0.2 %嘉兴: 0.2 %宁波: 0.2 %宁波: 0.2 %张家口: 4.6 %张家口: 4.6 %新乡: 0.2 %新乡: 0.2 %无锡: 0.2 %无锡: 0.2 %昆明: 0.6 %昆明: 0.6 %杭州: 0.6 %杭州: 0.6 %武汉: 0.5 %武汉: 0.5 %池州: 0.2 %池州: 0.2 %沧州: 0.2 %沧州: 0.2 %深圳: 0.3 %深圳: 0.3 %湖州: 0.2 %湖州: 0.2 %湛江: 0.2 %湛江: 0.2 %漯河: 0.3 %漯河: 0.3 %澳门: 0.2 %澳门: 0.2 %石家庄: 0.3 %石家庄: 0.3 %纽瓦克: 0.2 %纽瓦克: 0.2 %芒廷维尤: 38.1 %芒廷维尤: 38.1 %芝加哥: 0.2 %芝加哥: 0.2 %莫斯科: 0.9 %莫斯科: 0.9 %衡阳: 0.3 %衡阳: 0.3 %衢州: 0.2 %衢州: 0.2 %西宁: 23.9 %西宁: 23.9 %西安: 0.5 %西安: 0.5 %重庆: 0.5 %重庆: 0.5 %长春: 0.3 %长春: 0.3 %长沙: 0.9 %长沙: 0.9 %长治: 0.2 %长治: 0.2 %青岛: 0.5 %青岛: 0.5 %香港: 0.2 %香港: 0.2 %其他其他CanadaCentral DistrictIndiaKao-sungRochesterTaoyuan District[]上海东莞乌鲁木齐北京匹兹堡南京南宁厦门台州合肥吉林商洛嘉兴宁波张家口新乡无锡昆明杭州武汉池州沧州深圳湖州湛江漯河澳门石家庄纽瓦克芒廷维尤芝加哥莫斯科衡阳衢州西宁西安重庆长春长沙长治青岛香港

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (3343) PDF downloads(634) Cited by(3)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return